Viridian Therapeutics, Inc.

• Viridian Therapeutics, Inc. Estimates – TRADEGATE:1S1
  TradingView · 23 Oct 2026
• RBC raises Viridian Therapeutics target to $35
  scanx.trade · 23 Oct 2026
• Analyst Forecasts Just Became More Bearish On Viridian Therapeutics, Inc. (NASDAQ:VRDN)
  Simply Wall Street · 21 Oct 2026
• Viridian Therapeutics to report Q3FY26 results on November 4
  scanx.trade · 21 Oct 2026
• Press Release: Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
  富途牛牛 · 20 Oct 2026
• Viridian Therapeutics to Report Third Quarter 2026 Financial Results on November 4, 2026
  Business Wire · 20 Oct 2026
• Viridian Therapeutics presents 54 percent trial data for VRDN stock
  AD HOC NEWS · 20 Oct 2026
• Viridian Therapeutics presents phase 3 data: what it means for Viridian Therapeutics stock
  AD HOC NEWS · 18 Oct 2026
• Viridian Therapeutics (NasdaqCM:VRDN) Stock Forecast & Analyst Predictions
  Simply Wall Street · 16 Oct 2026
• Does Strong Lumvoa Launch Change The Bull Case For Viridian Therapeutics Stock (VRDN)?
  Simply Wall Street · 24 Sep 2026

Headlines from the last 30 days, linking to the original publishers. See all market news →